Ibex Medical Analytics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
99
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$55M
- Investors
-
12
Ibex Medical Analytics General Information
Description
Developer of an artificial intelligence-based diagnostics platform designed to assist pathology laboratories. The company offers software that uses machine learning and image analysis to analyze digitized pathology slides and detect cancer and multiple diagnostic features, enabling pathologists to improve diagnostic accuracy and efficiency.
Contact Information
Website
www.ibex-ai.comCorporate Office
- 101 Rokach Boulevard
- Tel Aviv 6153101
- Israel
Corporate Office
- 101 Rokach Boulevard
- Tel Aviv 6153101
- Israel
Ibex Medical Analytics Timeline
Ibex Medical Analytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series C) | 01-Sep-2023 | $55M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series B) | 20-Jul-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Debt - General | 25-Aug-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 13-Jul-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 09-Mar-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 09-Sep-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 19-Mar-2019 | $11M | $13.6M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Feb-2018 | $2.61M | $2.61M | Completed | Startup |
Ibex Medical Analytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B1 | ||||||||
| Preferred B | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 2,252,880 | $0.010000 | $4.88 | $4.88 | 1x | $4.88 | 21.09% | |
| Preferred A | 661,940 | $0.010000 | $3.94 | $3.94 | 1x | $3.94 | 6.2% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ibex Medical Analytics Comparisons
Industry
Financing
Details
Ibex Medical Analytics Competitors (26)
One of Ibex Medical Analytics’s 26 competitors is CancerLinQ, a Private Equity-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CancerLinQ | Private Equity-Backed | Cambridge, MA | ||||
| microDimensions | Formerly VC-backed | Cloppenburg, Germany | ||||
| Visiopharm | Private Equity-Backed | Hoersholm, Denmark | ||||
| Edda Technology | Venture Capital-Backed | Princeton, NJ | ||||
| SigTuple | Venture Capital-Backed | Bengaluru, India |
Ibex Medical Analytics Patents
Ibex Medical Analytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4111411-A1 | System and method of managing workflow of examination of pathology slides | Inactive | 26-Feb-2020 | ||
| EP-4111411-A4 | System and method of managing workflow of examination of pathology slides | Inactive | 26-Feb-2020 | ||
| US-20230068571-A1 | System and method of managing workflow of examination of pathology slides | Inactive | 26-Feb-2020 | ||
| WO-2021171281-A1 | System and method of managing workflow of examination of pathology slides | Inactive | 26-Feb-2020 | ||
| US-20220005582-A1 | System and method for personalization and optimization of digital pathology analysis | Inactive | 10-Oct-2018 | G16H30/20 |
Ibex Medical Analytics Signals
Ibex Medical Analytics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NewHealth Ventures | Venture Capital | Minority | ||
| Sienna Venture Capital | Venture Capital | Minority | ||
| Kreos Capital | Lender/Debt Provider | Minority | ||
| Octopus Ventures | Venture Capital | Minority | ||
| Planven | Venture Capital | Minority |
Ibex Medical Analytics FAQs
-
When was Ibex Medical Analytics founded?
Ibex Medical Analytics was founded in 2016.
-
Where is Ibex Medical Analytics headquartered?
Ibex Medical Analytics is headquartered in Tel Aviv, Israel.
-
What is the size of Ibex Medical Analytics?
Ibex Medical Analytics has 99 total employees.
-
What industry is Ibex Medical Analytics in?
Ibex Medical Analytics’s primary industry is Decision/Risk Analysis.
-
Is Ibex Medical Analytics a private or public company?
Ibex Medical Analytics is a Private company.
-
What is Ibex Medical Analytics’s current revenue?
The current revenue for Ibex Medical Analytics is .
-
How much funding has Ibex Medical Analytics raised over time?
Ibex Medical Analytics has raised $122M.
-
Who are Ibex Medical Analytics’s investors?
NewHealth Ventures, Sienna Venture Capital, Kreos Capital, Octopus Ventures, and Planven are 5 of 12 investors who have invested in Ibex Medical Analytics.
-
Who are Ibex Medical Analytics’s competitors?
CancerLinQ, microDimensions, Visiopharm, Edda Technology, and SigTuple are some of the 26 competitors of Ibex Medical Analytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process